Ticker,Title,Link
CRVS,Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference,9/3/2024 10:05:00 PM
CRVS,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Corvus Pharmaceuticals (CRVS), Vir Biotechnology (VIR) and Cooper Co (COO)",8/20/2024 10:50:47 AM
CRVS,Oppenheimer Sticks to Its Buy Rating for Corvus Pharmaceuticals (CRVS),8/7/2024 12:11:54 PM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.07 beats by $0.05,8/6/2024 10:07:16 PM
CRVS,Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL),8/1/2024 2:30:00 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024",7/31/2024 2:30:00 PM
CRVS,Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases,7/25/2024 2:30:00 PM
CRVS,The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now,5/31/2024 2:00:00 PM
CRVS,Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference,5/30/2024 10:02:00 PM
CRVS,Maintaining Neutral: A Balanced View on Corvus Pharmaceuticals Amid Promising Developments and Financial Prudence,5/10/2024 6:07:40 AM
CRVS,"NanoViricides, TC BioPharm, Holdco Nuvo among healthcare movers",5/7/2024 2:01:47 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results,5/6/2024 10:01:00 PM
CRVS,Corvus Pharmaceuticals Q1 2024 Earnings Preview,5/3/2024 9:20:12 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024",5/2/2024 10:02:00 PM
CRVS,Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis,4/9/2024 10:01:00 PM
CRVS,Hold Rating Maintained for Corvus Pharmaceuticals Amid Clinical Delays and Financing Concerns,3/29/2024 8:25:37 AM
CRVS,CRVS Stock Earnings: Corvus Pharma Misses EPS for Q4 2023,3/20/2024 12:53:23 AM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results,3/19/2024 9:02:00 PM
CRVS,Notable earnings after Tuesday's close,3/18/2024 9:35:27 PM
CRVS,"Earnings week ahead: FedEx, Nike, XPeng, Tencent, General Mills and more",3/17/2024 12:20:00 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024",3/13/2024 9:02:00 PM
CRVS,Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases,2/12/2024 2:30:00 PM
CRVS,"ABUS, PI and CAMP are among after hour movers",2/8/2024 10:13:43 PM
CRVS,Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer,2/6/2024 10:05:00 PM
CRVS,Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell,1/23/2024 11:00:00 PM
CRVS,Maintaining Hold Rating on Corvus Pharmaceuticals Amid Steady but Unspectacular Clinical Progress,12/13/2023 7:16:41 AM
CRVS,Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket,12/11/2023 1:59:29 PM
CRVS,Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial,12/9/2023 6:00:00 PM
CRVS,"Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Adaptimmune Therapeutics (ADAP) and Corvus Pharmaceuticals (CRVS)",11/10/2023 11:40:50 AM
CRVS,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Editas Medicine (EDIT), Corvus Pharmaceuticals (CRVS) and AC Immune SA (ACIU)",11/8/2023 6:41:16 AM
CRVS,"Analysts Conflicted on These Healthcare Names: Bioxcel Therapeutics (BTAI), Arcutis Biotherapeutics (ARQT) and Corvus Pharmaceuticals (CRVS)",9/12/2023 3:40:41 PM
CRVS,Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,9/7/2023 7:19:11 PM
CRVS,"CVRS, EDAP and EVLO are among after hour movers",9/6/2023 9:05:09 PM
CRVS,2 ‘Strong Buy’ Stocks Under $10 That Oppenheimer Sees Surging Over 200% — Here’s Why They Could Jump,8/30/2023 2:01:34 PM
CRVS,Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer,8/18/2023 8:23:59 PM
CRVS,Mizuho Securities Sticks to Their Hold Rating for Corvus Pharmaceuticals (CRVS),8/9/2023 5:55:24 PM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.14 in-line,8/8/2023 8:49:20 PM
CRVS,Corvus Pharmaceuticals Q2 2023 Earnings Preview,8/7/2023 9:35:30 PM
CRVS,Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session,7/10/2023 6:34:29 PM
CRVS,The Latest Analyst Ratings for Corvus Pharma,6/16/2023 9:00:35 PM
CRVS,Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,6/15/2023 7:12:48 PM
CRVS,3 High-Potential Penny Stocks to Buy Now,5/31/2023 12:11:38 PM
CRVS,"GEVO, LXRX and CRVS among mid-day movers",5/30/2023 5:14:47 PM
CRVS,"Enveric, Alimera top healthcare gainers; NanoString, Impel among losers",5/18/2023 2:04:28 PM
CRVS,Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,5/17/2023 6:51:50 PM
CRVS,Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session,5/15/2023 7:45:32 PM
CRVS,Mizuho Securities Sticks to Their Hold Rating for Corvus Pharmaceuticals (CRVS),5/9/2023 1:35:40 AM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.17 misses by $0.01,5/8/2023 8:28:06 PM
CRVS,7 High-Potential Penny Stocks in the Biotech Sector,5/4/2023 5:56:05 PM
CRVS,"CRVS, NAAS and GFAI among mid-day movers",4/12/2023 4:55:56 PM
CRVS,The 3 Best Biotech Stocks Under $1 to Buy for April,4/5/2023 12:21:04 AM
CRVS,Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS) and Caribou Biosciences (CRBU),3/29/2023 2:01:06 PM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.21 beats by $0.02,3/28/2023 8:06:40 PM
CRVS,Notable earnings after Tuesday's close,3/27/2023 9:35:09 PM
CRVS,Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session,12/13/2022 6:14:33 PM
CRVS,Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Corvus Pharmaceuticals (CRVS),11/4/2022 4:10:19 AM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.32 misses by $0.16,11/3/2022 8:32:24 PM
CRVS,"Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022",10/7/2022 4:03:24 PM
CRVS,Corvus' partner Angel Pharma gets nod to start phase 1/1b trial of cancer therapy in China,9/26/2022 9:13:04 PM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.18 in-line,8/8/2022 8:22:35 PM
CRVS,Notable earnings after Monday's close,8/7/2022 9:35:38 PM
CRVS,Corvus Pharmaceuticals Q2 2022 Earnings Preview,8/5/2022 9:35:44 PM
CRVS,"This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday",6/28/2022 10:23:47 AM
CRVS,"Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday",6/27/2022 10:26:40 AM
CRVS,"Catalyst watch: Rivian lockup expires, Western Digital event and inflation prints",5/6/2022 7:00:48 PM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.18,5/5/2022 9:34:56 PM
CRVS,Corvus Pharmaceuticals GAAP EPS of -$0.20 misses by $0.01,3/10/2022 9:14:25 PM
CRVS,Notable earnings after Thursday's close,3/9/2022 10:35:28 PM
CRVS,The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg,3/6/2022 4:02:06 PM
CRVS,"Brookdale, American Shared top healthcare gainers; Larimar, Omnicell  among losers",2/15/2022 3:00:53 PM
CRVS,"The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake",1/14/2022 2:07:14 PM
CRVS,"AU, SABR and REI among pre market gainers",12/1/2021 1:35:07 PM
CRVS,"The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance",11/10/2021 2:19:29 PM
CRVS,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",11/8/2021 2:24:25 PM
CRVS,Corvus Pharmaceuticals EPS misses by $0.03,11/1/2021 9:14:36 PM
CRVS,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",10/28/2021 2:26:10 PM
CRVS,Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818,10/26/2021 1:30:00 AM
CRVS,51 Biggest Movers From Yesterday,10/1/2021 10:44:15 AM
CRVS,"CRVS, ENG and LIZI among mid-day movers",9/30/2021 5:01:05 PM
CRVS,50 Biggest Movers From Yesterday,9/28/2021 11:07:42 AM
CRVS,31 Stocks Moving In Monday's Mid-Day Session,9/27/2021 6:00:19 PM
CRVS,"RWLK, CRVS and AEMD among mid-day movers",9/22/2021 4:37:59 PM
CRVS,"NNVC, RWLK and INDI among mid-day movers",9/21/2021 4:52:52 PM
CRVS,"ATER, GREE and BEST among mid-day movers",9/20/2021 5:51:12 PM
CRVS,Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet,9/17/2021 9:10:23 PM
CRVS,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,9/16/2021 11:35:53 AM
CRVS,65 Biggest Movers From Yesterday,9/3/2021 11:44:30 AM
CRVS,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",8/17/2021 2:28:53 PM
CRVS,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",8/5/2021 2:07:56 PM
CRVS,Corvus Pharmaceuticals EPS in-line,8/2/2021 8:40:42 PM
CRVS,20 Stocks Moving in Friday's Pre-Market Session,7/30/2021 1:00:31 PM
CRVS,Corvus Pharma praised for its focus after end to COVID-19 study,7/16/2021 5:45:06 PM
CRVS,Corvus shares drop after scrapping late-stage mupadolimab COVID-19 trial,7/15/2021 8:11:37 PM
CRVS,Corvus Pharmaceuticals initiated buy at Cantor with a Street-high target,5/27/2021 7:50:51 PM
CRVS,"The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics",5/19/2021 1:30:16 PM
CRVS,"The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO",5/18/2021 1:44:45 PM
CRVS,"The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron",5/12/2021 2:57:17 PM
CRVS,Corvus Pharma - In The Race To Fight Viral Variants ,5/6/2021 3:41:05 PM
CRVS,"QLYS, AVID, JRVR and EVK among after-hours movers",5/5/2021 9:45:37 PM
CRVS,Corvus Pharmaceuticals EPS beats by $1.16,3/25/2021 12:59:42 PM
CRVS,68 Biggest Movers From Yesterday,2/23/2021 10:58:31 AM
CRVS,50 Stocks Moving In Monday's Mid-Day Session,2/22/2021 6:00:15 PM
CRVS,"The Past Week's Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More",2/20/2021 8:17:02 PM
CRVS,"PETS, IMUX, EVGN and OTIC among after-hours movers",2/19/2021 10:46:06 PM
CRVS,"The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout",2/18/2021 2:14:38 PM
CRVS,"The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed",2/12/2021 2:10:51 PM
CRVS,"OGI, TWOU, FOLD and LLNW among after-hours movers",2/11/2021 10:50:46 PM
CRVS,"Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2021",2/10/2021 4:05:07 PM
CRVS,Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition,12/6/2020 4:00:00 PM
CRVS,Seeking Alpha Catalyst Watch,12/4/2020 8:30:00 PM
CRVS,Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition,11/30/2020 2:00:00 PM
CRVS,Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting,11/11/2020 10:05:00 PM
CRVS,Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting,11/9/2020 2:05:00 PM
CRVS,"Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing ",11/8/2020 3:52:03 PM
CRVS,Seeking Alpha Catalyst Watch,11/6/2020 8:30:45 PM
CRVS,Corvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Session at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting,11/2/2020 2:00:00 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results,10/29/2020 9:00:10 PM
CRVS,"AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Track ",10/7/2020 9:09:13 AM
CRVS,Stock Alert: Corvus Rise 30% On Positive Data From Early COVID Treatment Study ,10/5/2020 4:33:24 PM
CRVS,New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020,9/17/2020 9:01:10 AM
CRVS,"Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors",9/11/2020 2:30:10 PM
CRVS,Corvus Pharma Updates On Clinical Trial Of CPI-006 For Patients With COVID-19 - Quick Facts ,9/10/2020 3:29:29 PM
CRVS,Corvus Announces Participation in Upcoming Investor Conferences ,9/9/2020 12:02:10 AM
CRVS,Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference,8/4/2020 10:05:10 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results,7/30/2020 10:02:10 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020",7/23/2020 2:30:10 PM
CRVS,"CRVS, HEPA Jump On COVID-19 Drug Bandwagon, LVGO In Good Health, NVAX Joins $100 Stock Price Club ",7/8/2020 9:27:24 AM
CRVS,Stock Alert: Corvus Pharma Surges 111%; Study Initiated For COVID-19 Treatment ,7/7/2020 4:01:47 PM
CRVS,Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant ,5/29/2020 2:00:10 PM
CRVS,Corvus Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference,5/27/2020 2:00:10 PM
CRVS,Corvus Pharmaceuticals to Present Data on Refinement of the Adenosine Gene Signature and Ciforadenant in Renal Cell Cancer at the ASCO20 Virtual Scientific Program,5/13/2020 11:23:10 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results,4/30/2020 10:05:10 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2020 Financial Results on April 30, 2020",4/22/2020 2:30:10 PM
CRVS,Corvus Pharma files to offer up to $50M in stock,3/20/2020 10:32:18 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results,3/5/2020 10:05:00 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter 2019 Financial Results on March 5, 2020",2/28/2020 10:01:00 PM
CRVS,Richard Miller Awarded 2020 Drug Hunter Award by UC Drug Discovery Consortium,2/19/2020 10:05:00 PM
CRVS,"Corvus lead drug in prostate cancer fails to excite investors, shares down 14%",2/13/2020 4:01:58 PM
CRVS,Key events next week - healthcare,2/7/2020 2:47:42 PM
CRVS,Lineage Cell Therapeutics among healthcare gainers; ReWalk Robotics leads the losers,2/6/2020 4:01:39 PM
CRVS,Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum,2/1/2020 8:00:00 PM
CRVS,Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting,12/7/2019 3:00:00 PM
CRVS,"Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch ",12/4/2019 2:38:26 AM
CRVS,Corvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting,11/8/2019 1:00:00 PM
CRVS,Corvus Pharmaceuticals to Present Preclinical and Early Clinical Data from the Phase 1/1b Trial with  CPI-818 at the American Society of Hematology (ASH) Annual Meeting,11/7/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present at the 28th Annual Credit Suisse Healthcare Conference,11/5/2019 2:30:00 PM
CRVS,"Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 8, 2019",11/4/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results,10/29/2019 9:05:05 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2019 Financial Results on October 29, 2019",10/17/2019 2:30:05 PM
CRVS,"5 Top Gainers In Healthcare Sector (RARX, ONCS, MREO…) ",10/11/2019 3:28:57 AM
CRVS,Corvus Pharmaceuticals to Present Updated Data from CPI-006 Clinical Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting,10/3/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present at the 2019 Wedbush Healthcare Conference ,8/7/2019 10:05:00 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2019 Financial Results on August 1, 2019",7/24/2019 10:15:00 PM
CRVS,"6 Top Gainers In Healthcare Sector (AMRN, DOVA, IMUX...) ",7/3/2019 4:12:18 AM
CRVS,Corvus Pharmaceuticals Presents Initial CPI-006 Phase 1/1b Clinical Data at 2019 ASCO Annual Meeting,6/2/2019 4:45:00 PM
CRVS,Corvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference,5/28/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present Initial Clinical Data from CPI-006 Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting,5/16/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results,5/9/2019 10:02:00 PM
CRVS,"Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2019 Financial Results on May 9, 2019",5/1/2019 10:10:00 PM
CRVS,Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update,3/7/2019 10:10:00 PM
CRVS,Corvus Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference,3/5/2019 10:15:00 PM
CRVS,Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference,2/6/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present Updated Biomarker and Clinical Data on Lead Development Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference,1/30/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals Announces Appointment of New Member of Board of Directors and Hiring of Chief Medical Officer,1/28/2019 10:05:00 PM
CRVS,"Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas",1/10/2019 2:30:00 PM
CRVS,"Corvus Announces Enrollment in Second Arm of Phase 1/1b Dose-Escalation Trial of Anti-CD73 Antibody, CPI-006, Focused on Combination with CPI-444 Adenosine Antagonist",1/8/2019 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present at the 27th Annual Credit Suisse Healthcare Conference,11/12/2018 2:30:00 PM
CRVS,"Corvus Pharmaceuticals Announces Updated Results from Ongoing Clinical Studies of  Lead Programs, CPI-444 and CPI-006, at SITC 33rd Annual Meeting",11/10/2018 11:00:00 PM
CRVS,"Corvus Pharmaceuticals to Webcast Investor & Analyst Event on November 10, 2018",11/6/2018 12:31:15 AM
CRVS,Corvus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update,11/1/2018 9:10:00 PM
CRVS,Corvus Pharmaceuticals Announces New Data on Adenosine Gene Signature Biomarker Associated with Patient Response to CPI-444 at European Society for Medical Oncology (ESMO) 2018 Congress,10/22/2018 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present Data on Lead Programs at the European Society for Medical Oncology (ESMO) 2018 Congress and the Society for Immunotherapy of Cancer (SITC) Annual Meeting,10/4/2018 10:15:00 PM
CRVS,Corvus Pharmaceuticals Announces Publication of Preclinical Results Highlighting Antitumor Activity of CPI-444 in Multiple Tumor Models both as Monotherapy and in Combination Studies,10/3/2018 10:15:00 PM
CRVS,Corvus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference,9/25/2018 10:15:00 PM
CRVS,Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update,8/2/2018 10:15:00 PM
CRVS,Corvus Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference,7/31/2018 10:15:00 PM
CRVS,"Corvus Pharmaceuticals Announces Publication of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity as Monotherapy and in Combination with Anti-PD-1 Therapy in Cancer Immunology,...",6/28/2018 2:30:00 PM
CRVS,Corvus Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference,5/30/2018 10:15:00 PM
CRVS,Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update,5/3/2018 10:10:00 PM
CRVS,BRIEF-Corvus Pharmaceuticals Announces Initiation Of Phase 1/1B Clinical Trial Of CPI-006 In Patients With Advanced Cancer,4/26/2018 2:55:07 PM
CRVS,"EKSO Leaps, FDA Nod For DRIO, CRVS Up 38% This Month, VTL To Report Data In Sep. ",3/27/2018 2:54:28 AM
CRVS,Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock,3/12/2018 2:15:00 PM
CRVS,Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock,3/8/2018 3:04:42 PM
CRVS,Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock,3/7/2018 10:06:00 PM
CRVS,Corvus Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference 2018,3/6/2018 2:30:00 PM
CRVS,Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update,3/1/2018 10:10:00 PM
CRVS,Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhibitor at 10th Annual T-Cell Lymphoma ForumCompany’s Investigational Small...,2/1/2018 2:30:00 PM
CRVS,Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential Use in Patient Selection,11/11/2017 11:45:00 PM
CRVS,Corvus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Clinical Program Update,11/2/2017 9:10:00 PM
CRVS,"MBIO Keeps Galloping, GERN On Fast Track, APVO Awes, INSY Continues Descent ",11/1/2017 2:55:41 AM
CRVS,Corvus Pharmaceuticals to Present Data on Lead Checkpoint Inhibitor CPI-444 at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting,10/18/2017 10:10:00 PM
CRVS,Corvus Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference,9/20/2017 10:10:00 PM
CRVS,"CDNA Soars On Medicare Decision, BOLD Data In Sep., NBRV Slumps Before LEAP ",8/25/2017 3:49:19 AM
CRVS,"Gainers & Losers Of Aug.23: ITCI, PRTK, MBIO, RARE, OVID... ",8/24/2017 4:09:05 AM
CRVS,"Gainers & Losers Of June 6: VTL, EGLT, AMRI, AGLE, CRVS... ",6/7/2017 3:30:46 AM
CRVS,"INNL To Be Acquired, ELGX Seeks Funds, Opdivo At FDA Altar Again, NLNK Abuzz ",4/5/2017 8:28:48 AM
